TechNavio's analysts forecast the Global
Heparin market to grow at a CAGR of 11.2 percent over the period
2011-2015. One of the key factors contributing to this market growth is
the increase in aging population. The Global Heparin market has also
been witnessing the trend of an increase in RandD activities by the
vendors to expand the focus area for heparin drugs and to capture the
major share of the market. However, the patent expiry of top-selling
drugs could pose a challenge to the growth of this market.
report, the Global Heparin Market 2011-2015, has been prepared based on
an in-depth market analysis with inputs from industry experts. The
report covers the Americas, and the EMEA and APAC regions; it also
covers the Global Heparin market landscape and its growth prospects in
the coming years. The report also includes a discussion of the key
vendors operating in this market.
The key vendors dominating this market space are Sanofi S.A., Pfizer Inc., GlaxoSmithKline plc., and Leo Pharma Inc.
other vendors mentioned in the report are Bristol-Myers Squibb Co.,
Teva Pharmaceutical Industries Ltd., Wanbang Biochemical Pharmaceutical
Co. Ltd., Celgene Corp., Mitsubishi Tanabe Pharma Corp., Baxter
Healthcare Corp., and Shanghai No. 1 Biochemical Pharmaceutical Co. Ltd.
Key questions answered in this report: What will the market size be in 2015 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? You can request one free hour of analyst time when you purchase this report. Details provided within the report.
research portfolio in the Healthcare series includes reports on the
Pharmaceutical Market, Medical Devices Market, Diagnostic Market,
Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing
Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy
Market, Dialysis Market, Telemedicine Market, Cancer Drug Market,
Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market,
Neuromodulation Market, Capnography Market.
01. Executive Summary 02. Introduction 03. Market Coverage Market Overview Product Offerings 04. Market Landscape Market Size and Forecast 04.1 Five Forces Analysis 05. Geographical Segmentation 06. Vendor Landscape 07. Buying Criteria 08. Market Growth Drivers 09. Drivers and their Impact 10. Market Challenges 11. Impact of Drivers and Challenges 12. Market Trends 13. Key Vendor Analysis 13.1 Sanofi S.A. Business Overview SWOT Analysis 13.2 Pfizer Inc. Business Overview SWOT Analysis 13.3 GlaxoSmithKline plc Business Overview SWOT Analysis 13.4 Leo Pharma Inc. Business Overview SWOT Analysis 14. Other Reports in this Series
List of Exhibits: Exhibit 1: Global Heparin Market 2011-2015 (US$ billion) Exhibit 2: Global Heparin Market by Geographical Segmentation 2011 Exhibit 3: Global Heparin Market by Vendor Segmentation 2011 Exhibit 4: Business Segmentation of Sanofi S.A. Exhibit 5: Business Segmentation of Pfizer Inc. Exhibit 6: Business Segmentation of GlaxoSmithKline plc